financetom
Market
financetom
/
Market
/
Maruti Suzuki Q3: Net profit down 48% at Rs 1,011 crore, beats Street estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Maruti Suzuki Q3: Net profit down 48% at Rs 1,011 crore, beats Street estimates
Jan 25, 2022 5:02 AM

Maruti Suzuki on Tuesday reported a net profit of Rs 1,011 crore for the quarter ended December, beating Street estimates. However, the quarterly net profit of the country's largest carmaker was down 47.9 percent on a year-on-year basis.

Maruti Suzuki's revenue for the December quarter was at Rs 23,246 crore, down 0.9 percent compared with the corresponding period a year ago.

Analysts in a CNBC-TV18 poll had predicted the company's quarterly profit at Rs 860 crore and revenue at Rs 23,051 crore.

The auto major reported Rs 1,559 crore in earnings before interest, taxes, depreciation and amortisation (EBITDA) for the third quarter of the current financial year. The EBITDA saw a decline of 30 percent on year.

Its margin came in at 6.7 percent in the December quarter as against 9.5 percent in the year-ago period.

Analysts had estimated Maruti Suzuki's EBITDA at Rs 1,261 crore and the EBITDA margin at 5.4 percent.

Maruti Suzuki shares rose as much as 7.6 percent to Rs 8,661.6 apiece on BSE after the earnings announcement. It closed at Rs 8,600.6 apiece for the day, up 6.7 percent.

Market expert Prakash Diwan said Maruti Suzuki's quarterly numbers are definitely a big big relief. "It is a great recovery process that seems to have begun... The raw material input side has been fairly benign for the second half of the quarter in terms of some of the costs on the metal and commodities side coming down," he said.

He said the current valuation multiple enjoyed by Maruti Suzuki is fairly high.

Also, catch live updates from the stock market with CNBC-TV18.com's blog

First Published:Jan 25, 2022 2:02 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UnitedHealth Group Q3 Earnings Preview: Dow Jones Industrial Average Stock Could 'Move Markets' Tuesday
UnitedHealth Group Q3 Earnings Preview: Dow Jones Industrial Average Stock Could 'Move Markets' Tuesday
Oct 14, 2024
With the Dow Jones Industrial Average at all-time highs, the earnings report from UnitedHealth Group ( UNH ) on Tuesday before the market open could be of particular interest. Earnings Estimates: Analysts expect UnitedHealth ( UNH ) to report third-quarter revenue of $99.28 billion, up from $92.36 billion in last year's third quarter, according to data from Benzinga Pro. The...
Dow Settles Above 43K For First Time Ahead Of Big Earnings: Fear Index Moves To 'Extreme Greed' Zone
Dow Settles Above 43K For First Time Ahead Of Big Earnings: Fear Index Moves To 'Extreme Greed' Zone
Oct 15, 2024
The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the “Extreme Greed” zone on Monday. U.S. stocks settled higher on Monday, with the Dow Jones index closing the session above the 43,000 level for the first time. The S&P 500 also surged to record highs during the session. U.S....
Russian rouble strengthens against yuan, weakens vs US dollar
Russian rouble strengthens against yuan, weakens vs US dollar
Oct 15, 2024
MOSCOW, Oct 15 (Reuters) - The Russian rouble strengthened against China's yuan but weakened against the U.S. dollar, reflecting global forex trends and weaker oil as trade in the Chinese yuan continued uninterrupted. By 0830 GMT, the rouble was up 0.8% at 13.35 against the yuan in the over-the counter (OTC) market, according to LSEG data. It was down 1.2%...
Sector Update: Health Care
Sector Update: Health Care
Oct 14, 2024
03:32 PM EDT, 10/14/2024 (MT Newswires) -- Health care stocks were rising late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.6%. The iShares Biotechnology ETF (IBB) rose 0.2%. In corporate news, Tevogen Bio ( TVGN ) shares surged nearly 219%. The company said it plans to outline pipeline...
Copyright 2023-2026 - www.financetom.com All Rights Reserved